pTRAc/pRIC 3.0

Protein Expression Prokaryotic cells - A. tumefaciens BFDV cp

Experiment
Protein Expression Prokaryotic cells - A. tumefaciens BFDV cp
Product
pTRAc/pRIC 3.0 from Inga I. Hitzeroth, Biopharming Research Unit, Department of Mole
Manufacturer
Inga I. Hitzeroth, Biopharming Research Unit, Department of Mole

Protocol tips

Protocol tips
The A. tumefaciens GV3101::pMP90RK cells were electroporated using 40–400 ng of recombinant plasmid as described by Maclean, et al. [44]. Recombinant clones were selected using agar plates containing kanamycin (30 μg/mL), rifampicin (50 μg/mL) and carbenicillin (50 μg/mL) and incubated at 27° C.

Publication protocol

"The A. tumefaciens GV3101::pMP90RK cells were electroporated using 40–400 ng of recombinant plasmid as described by Maclean, et al. [44]. Recombinant clones were selected using agar plates containing kanamycin (30 μg/mL), rifampicin (50 μg/mL) and carbenicillin (50 μg/mL) and incubated at 27° C.

For infiltration, recombinant A. tumefaciens GV3101::pMP90RK were grown up overnight at 27° C with agitation in induction medium supplemented with kanamycin (30 μg/mL), rifampicin (50 μg/mL) and carbenicillin (50 μg/mL) [45]. The strain LBA4404 containing pBIN-NSs, provided by Marcel Prins from the Laboratory of Virology, Wageningen in the Netherlands, was supplemented with kanamycin (30 μg/mL), rifampicin (50 μg/mL) and 2 mM MgSO4. The addition of MgSO4 was to prevent cell clumping during incubation [44]. The NSs protein has been shown to suppress post-transcriptional gene silencing in plants, leading to an increase in transient protein expression [46]. Cells were harvested by centrifugation at 4000 g for 10 min, and resuspended in infiltration medium [45]. The suspensions were diluted to the required absorbance (OD600), for expression optimisation studies a range of OD600 values were tested, using an Ultrospec™ 10 Cell density meter (Amersham Biosciences, United Kingdom) and incubated at 22° C for 2 h. The A. tumefaciens GV3101::pMP90RK suspensions of each expression construct were co-infiltrated with strain LBA4404 containing pBIN-NSs into 6-week-old N. benthamiana plants by injecting the suspension into the abaxial spaces using a needleless 1 mL syringe. The plants were maintained in a greenhouse under a 16 h light and 8 h dark photoperiod at light intensity of 60–80 μE/m2/s and 22° C.

Vacuum infiltration of A. tumefaciens into N. benthamiana was performed as described by Maclean, et al. [44], with the following modifications. The Agrobacterium strains were combined in infiltration medium for a final OD600 of 1.00 for strain GV3101::pMP90RK and 0.25 for strain LBA4404 making a total OD600 of 1.25. The 6-week-old N. benthamiana plants were prepared for inversion into infiltration medium by sealing the base of the plant through the use of a 130 × 130 mm acrylic sheet that contained a 10 mm channel to the centre to allow for the plant stem to be inserted (Fig. 4). This prevented soil from falling into the infiltration medium while the plant was inverted and leaves and stem submerged."

Full paper   Login or join for free to view the full paper.

Reviews

pTRAc/pRIC 3.0 from Inga I. Hitzeroth, Biopharming Research Unit, Department of Mole has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Protein Expression Prokaryotic cells - A. tumefaciens BFDV cp using pTRAc/pRIC 3.0 from Inga I. Hitzeroth, Biopharming Research Unit, Department of Mole.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Inga I. Hitzeroth, Biopharming Research Unit, Department of Mole for pTRAc/pRIC 3.0 below.

We haven't found the manufacturer protocol for this product yet.

Videos

Check out videos that might be relevant for performing Protein Expression Prokaryotic cells - A. tumefaciens BFDV cp using pTRAc/pRIC 3.0 from Inga I. Hitzeroth, Biopharming Research Unit, Department of Mole. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms